NOVAVAX INC (NVAX)       16.52  -0.33 (-1.96%)

16.52  -0.33 (-1.96%)

US6700024010 - Common Stock - After market: 16.4 -0.12 (-0.73%)

Buy % Consensus

76
Analysts have set a mean price target of 82.96. This target is 402.18% above the current price.
NVAX was analyzed by 14 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about NVAX.
In the previous month the buy percentage consensus was at a similar level.
NVAX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 16.5216.1670.3882.96217.35 - -2.18% 326.03% 402.18% 1,215.68%

Up and Down Grades

Date Firm Action Rating
2022-10-14 B. Riley Securities Maintains Buy
2022-09-22 JP Morgan Downgrade Neutral -> Underweight
2022-08-09 Cowen & Co. Maintains Outperform
2022-06-08 Cantor Fitzgerald Maintains Overweight
2022-05-20 B of A Securities Initiate Underperform
2022-04-26 B. Riley Securities Maintains Buy
2022-03-03 HC Wainwright & Co. Maintains Buy
2022-01-21 Cowen & Co. Initiate Outperform
2021-12-21 JP Morgan Maintains Neutral
2021-06-15 Cantor Fitzgerald Maintains Overweight
2021-05-12 Cantor Fitzgerald Maintains Overweight
2021-05-12 JP Morgan Downgrade Overweight -> Neutral
2021-05-12 HC Wainwright & Co. Maintains Buy
2021-03-12 HC Wainwright & Co. Maintains Buy
2021-02-18 B. Riley FBR Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA